PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma

<i>Background:</i> Since emerging evidence suggests a protective role of proprotein convertase subtilisin/kexin type 9 (PCSK9) on hepatitis C virus (HCV) infection, the aim of the present study was to evaluate the correlation between PCSK9 and HCV infection in hepatocellular carcinoma (H...

Full description

Bibliographic Details
Main Authors: Silvano Fasolato, Sabrina Pigozzo, Patrizia Pontisso, Paolo Angeli, Massimiliano Ruscica, Edoardo Savarino, Sara De Martin, Maria Giovanna Lupo, Nicola Ferri
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
PCSK9
hepatocellular carcinoma
HCV
cholesterol
Online Access:https://www.mdpi.com/2077-0383/9/10/3134

Internet

https://www.mdpi.com/2077-0383/9/10/3134

Similar Items